Abstract
Mitochondrial membrane permeabilization is a rate-limiting step of cell death. This process is, at least in part, mediated by opening of the permeability transition pore complex (PTPC) Several soluble proteins from the mitochondrial intermembrane space and matrix are involved in the activation of catabolic hydrolases including caspases and nucleases. We therefore investigated the composition of a mixture of proteins released from purified mitochondria upon PTPC opening. This mixture was subjected to a novel proteomics/mass spectrometric approach designed to identify a maximum of peptides. Peptides from a total of 79 known proteins or genes were identified. In addition, 21 matches with expressed sequence tags (EST) were obtained. Among the known proteins, several may have indirect or direct pro-apoptotic properties. Thus endozepine, a ligand of the peripheral benzodiazepin receptor (whose occupation may facilitate mitochondrial membrane permeabilization), was found among the released proteins. Several proteins involved in protein import were also released, namely the so-called X-linked deafness dystonia protein (DDP) and the glucose regulated protein 75 (grb75), meaning that protein import may become irreversibly disrupted in mitochondria of apoptotic cells. In addition, a number of catabolic enzymes are detected: arginase 1 (which degrades arginine), sulfite oxidase (which degrades sulfur amino acids), and epoxide hydrolase. Although the functional impact of each of these proteins on apoptosis remains elusive, the present data bank of mitochondrial proteins released upon PTPC opening should help further elucidation of the death process. Cell Death and Differentiation (2000) 7, 137–144
Similar content being viewed by others
Introduction
Apoptosis is (almost) uniformly accompanied by an increase in mitochondrial membrane permeability,1,2 that is triggered by an ever increasing number of different pro-apoptotic effectors, including caspases,3,4 pro-apoptotic members of the Bcl-2/Bax family,5,6,7 lipid second messengers such as ganglioside GD3,8 Ca2+, or pro-oxidants.9,10,11 The permeabilization of the inner membrane is partial, allowing for the free diffusion of solutes of up to 1500 Da and may be reversible.1,2 In contrast, permeabilization of the outer membrane is complete, culminating in the release of soluble intermembrane space proteins (SIMPs). The mechanism accounting for membrane permeabilization is a matter of debate. At least in some models, it involves proteins of the permeability transition pore complex (PTPC) whose most abundant components, the voltage dependent anion channel (VDAC) and the adenine nucleotide translocator (ANT), interact with pro- and anti-apoptotic members of the Bcl-2/Bax family.6,12 How SIMPs are released from mitochondria is not understood. According to one hypothesis, the liberation of SIMPs may result from ANT-mediated inner membrane permeabilization6,13 with consequent matrix swelling and physical disruption of the outer membrane.14 However, it has also been suggested that VDAC may form a protein-permeable conduit.12
Irrespective of the exact mode of outer membrane permeabilization, it appears that the release of SIMPs occurs in a non-selective fashion and indistinguishably affects relatively small proteins such as cytochrome c (14.5 kDa),15 as well as larger proteins such as the adenylate kinase-2 (50 kDa),16,17 apoptosis inducing factor (AIF, 57 kDa),18,19 and mitochondrial caspases (up to 50 kDa).20,21 Several among these SIMPs are highly apoptogenic, thus providing a molecular link between mitochondrial dysfunction and the activation of catabolic hydrolases. Thus, cytochrome c and hsp 10 (which translocate into the cytosol) participate in the activation of caspases within the apoptosome,15,22 whereas AIF (which translocates into the nucleus) activates endonucleases and may account for caspase-independent large scale chromatin condensation.19,23
Intrigued by the fact that several mitochondrial proteins are involved in the apoptotic process, we decided to investigate the composition of a mixture of proteins released from purified mitochondria upon PTPC opening. This mixture was subjected to a novel mass spectrometric approach designed to identify as many peptides as possible.24,25,26 Here we report the identification of 97 mitochondrial proteins, some of which may contribute to the cell death cascade.
Results and Discussion
Creation of a protein data base
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) was employed to investigate the peptide composition of trypsin-digested supernatants, obtained from mouse liver mitochondria treated with the PTPC-opening agent atractyloside. This supernatant contained multiple proteins with a maximum size of ∼80 kDa (Figure 1) and clearly differed in its composition from other submitochondrial fractions. Thus, when compared to the intermembrane space fraction of proteins, a lower content of proteins with a molecular mass greater than 80 kDa and a clear bias in favor of smaller proteins was found (Figure 1). The LC-MS/MS technology was applied either to the unfractionated peptide mixture or to a batch of peptides that had been enriched based on their cysteine content, as detailed in Materials and Methods. Proteins were identified by correlation of their peptide sequence with an uninterpreted MS/MS spectrum. Obvious contaminants (trypsin and 15 peptides corresponding to 10 different ribosomal proteins) were excluded from the pool of proteins which are listed in Table 1. Peptides corresponding to a total of 79 known proteins or genes were identified. In addition, 21 matches with expressed sequence tags (EST) were obtained. Of note, several SIMPs that are known to be released from mouse liver mitochondria exposed to atractyloside (such as AIF or caspases 2 and 9)19,20 were not detected, indicating that this protein data base must be regarded as incomplete. These proteins are most likely at levels at or below that of the contaminants (ribosomal proteins) identified in the sample.
As to be expected, most of the proteins whose subcellular localization has been previously assessed are mitochondrial proteins. A lysosomal contamination might be suggested by the detection of cathepsin B. However, cathepsin B has been previously found in the supernatant of atractyloside treated mitochondria,27 and this may indicate that some of this protease is actually imported into mitochondria and/or associates with mitochondria. Several proteins which are normally considered as peroxisomal were also detected. Again, it is possible that this is due to a minor contamination of mitochondria with peroxisomes. Alternatively, it may be indicative of a dual (peroxisomal plus mitochondrial) localization of such proteins, which has been observed.28,29,30 A large number of proteins that are classified as matrix proteins were identified. This may constitute a fraction of proteins that are being imported (through the intermembrane space) or, alternatively, suggest that some mitochondria (partially?) lose the integrity of the inner mitochondrial membrane.22,31 In accord with this latter possibility, mitochondria treated with the PTPC activator Bax release the matrix protein aspartate aminotransferase32 and some translocation of the matrix protein hsp60 into the cytosol has been reported to occur in cells undergoing apoptosis.22 The release of hsp60, however, is not detectable by immunofluorescence staining, indicating that it only affects a minor fraction of the pool of hsp60.22,31 We have verified the subcellular localization of two proteins found in the data base, namely X-linked deafness dystonia protein (DDP, which is an intermembrane protein) and SOD2 (which is a matrix protein). As to be expected from their submitochondrial localization, DDP distributed from mitochondria (counterstained with the matrix protein hsp60) to the cytosol when apoptosis was induced (Figure 2A). In contrast, SOD2 remained mitochondrial (Figure 2B), meaning that only a minority of SOD2, if any, was liberated from mitochondria following apoptosis induction.
Concluding remarks
The data contained in Table 1 confirm the non-selective nature of mitochondrial membrane permeabilization. In addition to known apoptogenic SIMPs, a number of different proteins which might have some impact on cell death were identified. Thus acyl-CoA binding protein (diazepam binding inhibitor, also called endozepine) and a putative analogue (corresponding to EST AA930535) were found in the mitochondrial supernatant. We and others have found in the past that ligation of the mitochondrial benzodiazepine receptor (whose endogenous ligand is acyl-CoA binding protein) causes PT pore opening and favors apoptosis.33,34,35,36 It is tempting to speculate that endozepine released from mitochondria undergoing PT may affect other mitochondria. Several proteins involved in protein import were also released, namely the so-called X-linked deafness dystonia protein (DDP)37 and the glucose regulated protein 75 (grb75). This may imply that protein import becomes disrupted in mitochondria, making the outer membrane damage irreversible. Moreover, grb75 has been reported to interact with p53.38 The mass spectrometric data indicate that several antioxidant enzymes were released from mitochondria. This applies to glutathione peroxidase, thioredoxin, thioredoxin peroxidase, and perhaps a fraction of manganese-dependent superoxide dismutase (SOD2), suggesting a relative deprotection of mitochondrial membranes from oxidative reactions. Accordingly, an enhanced local generation of superoxide anion and the oxidation of mitochondrial cardiolipin has been found to occur shortly after mitochondrial membrane permeabilization in intact cells.39 Finally, a number of catabolic enzymes are detected in the SIMPs fraction: arginase 1 (which degrades arginine), sulfite oxidase (which degrades sulfur amino acids), and epoxide hydrolase. Such enzymes might deplete essential metabolites, thereby decreasing anabolic reactions and/or affecting energy metabolism.
The evaluation of each of these proteins in the context of apoptosis remains elusive. However, the data base of mitochondrial proteins contained in this article should prove useful for further investigation of cell death mechanisms.
Materials and Methods
Preparation of protein samples
Mitochondria (1 mg protein/ml) were purified from mouse liver on a Percoll gradient as previously described,40 resuspended in CFS buffer (220 mM mannitol; 68 mM sucrose, 2 mM NaCl, 2.5 mM KH2PO4, 0.5 mM EGTA, 2 mM MgCl2, 5 mM pyruvate, 0.1 mM phenylmethyl sulfonylfluoride, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, 50 μg/ml antipain, 10 μg/ml chymopapain, 1 mM dithiotreitol, 10 mM HEPES-NaOH, pH 7.4) and incubated in the presence of atractyloside (5 mM, 30 min, RT), followed by centrifugation (7000×g, 10 min, 4°C), recovery of the supernatant and ultracentrifugation (1.5×105×g, 1 h, 4°C). This sample was subjected to LC-MS/MS. In addition, submitochondrial fractions were purified by standard procedures41 and the samples were analyzed by SDS–PAGE (15%), followed by silver staining.
LC-MS/MS of unfractionated proteins
Forty μg of protein was dried, resuspended in 500 μL of 30 mM Tris-HCl, pH 7.0/8 M urea/10 mM dithiotreitol, and incubated for 30 min at 37°C. The sample was alkylated with 20 mM iodoacetamide for 30 min at room temperature in the dark, then buffer exchanged into 30 mM Tris-HCl, pH 7.0/2 M urea at 4°C using a Centricon YM-3 (3,000 MW cutoff, Amicon, Beverly, MA, USA). Digestion was initiated with the addition of 1.5 μg trypsin (Sequencing Grade, Boehringer Mannheim, Indianapolis, IN, USA) and incubated overnight at 37°C. The digest was acidified with 30 μL 10% TFA. LC-MS/MS analysis was performed using a Hewlett Packard 1100 HPLC system (Hewlett-Packard, Palo Alto, CA, USA) connected on-line with a 1 : 1 splitter to a Finnigan LCQ iontrap mass spectrometer (Thermoquest, San Jose, CA, USA) as described.42 Peptides were separated on a C18 1.0×250 mm column (Vydac, Hesperia, CA, USA) using a flow rate of 60 μl/min, with the UV monitored at 215 nm. Solvent A was 0.1% formic acid/H2O, and solvent B was 0.09% formic acid/H2O/90% acetonitrile. The gradient consisted of 3% B isocratic for 15 min, a linear gradient to 60% B in 57 min, to 90%B in 15 min, isocratic at 90%B for 15 min, and then to 3% B in 5 min. To determine the amount to load for subsequent runs, an aliquot of the digest (∼8 μg) was analyzed using the ‘triple play’ feature for data-dependent ion selection and fragmentation (MS, zoom MS, MS/MS) with precursor ion selection over the mass range 400–2000 m/z. With the Finnigan Navigator software (Thermoquest, San Jose, CA, USA), an isotope exclusion width of 5 and a dynamic exclusion time of 1.0 min were utilized and a relative collision energy of 40 was set. The remaining digest (∼32 μg) was aliquoted into three samples and analyzed as above but with different ion selection criteria. The ion selection criteria for the triple play utilized one of the mass ranges of 400–615, 585–815, and 785–2000 m/z for each analysis. Finnigan.RAW files were converted to .txt files, then fragment ion spectra were searched against non-redundant protein sequence and translations of EST databases.42,43 Potential peptide matches were visually confirmed.
Reversible cysteine biotinylation of peptide mixture
One-hundred-and-twenty μg sample was vacuum concentrated and resuspended in 1 mL of 40 mM Tris-HCl/pH 7.0/8 M urea/10 mM dithiotreitol, then incubated for 30 min at 37°C. The sample was buffer exchanged into PBS/ 1 mM EDTA/ 2 M urea using a Centricon YM-3 (3000 MW cutoff) at 4°C. Fifty μl of 4 mM EZ-Link TMBiotin-HPDP (Pierce, Rockford, IL, USA) in DMSO was added and the sample incubated at room temperature for 90 min. To remove excess free Biotin-HPDP the sample was buffer exchanged again into PBS/1 mM EDTA/2 M urea, followed by trypsin digestion as above. An 1 mL Immobilized-Avidin column (Pierce, Rockford, IL, USA) was equilibrated with 5 ml PBS/1 mM EDTA. The biotinylated digest was applied to the column and incubated for 30 min at room temperature. The avidin column was washed with 10 mL PBS/1 mM EDTA (yielding the flowthrough fraction). Two mL of PBS/50 mM dithiotreitol was added to elute any bound peptides (yielding the bound fraction). Both the avidin flowthrough fraction and the avidin bound fraction were alkylated (using 10 and 100 mM iodoacetamide respectively) for 30 min at room temperature. The fractions were acidified with formic acid, desalted using an Oasis cartridge (Waters, Milford, MA, USA), vacuum concentrated, and then resuspended in 100 μl 0.1% formic acid. LC-MS/MS analysis was performed using the above listed parameters but with a C18 0.05×150 mm column (MetaChem Technologies Inc., Torrance, CA, USA) and a flow rate of 25 μl/min without splitting directly into the mass spectrometer. Four separate LC-MS/MS runs using separate narrow mass ranges for ion selection (400–575, 565–715, 685–970, and 935–2000 m/z) were used for the flowthrough fraction and the bound fraction was analyzed using the single broad mass range (400–2000 m/z for ion selection. Spectra were handled as described above.
Immunofluorescence
Mouse embryonic fibroblasts were cultured in the absence or presence of the apoptosis inducer staurosporin (STS; 2 μM, 4 h; Sigma). A rabbit antiserum generated against DDP 37 was used (diluted 1/20) on paraformaldehyde (4% w:v) and picric acid-fixed (0.19% v:v) cells (cultured on 100 μm cover slips; 18 mm Ø; Superior, Germany), and revealed with a goat anti-rabbit IgG conjugated to phycoerythrine (PE) (Southern Biotechnology, Birmingham, AL, USA). A sheep antiserum specific for SOD2 (Calbiochem, San Diego, CA, USA) was revealed by means of a rabbit anti-sheep IgG fluorescein isothiocyanate (FITC) conjugate (Southern Biotechnology). Cells were counterstained for the detection of hsp60 (mAb H4149 from Sigma, revealed by a goat anti-mouse IgG FITC or PE conjugate; Southern Biotechnology). Confocal microscopy was performed on a Leica TC-SP (Leica Microsystems, Heidelberg, Germany) equipped with an ArKr laser mounted on an inverted Leica DM IFBE microscope with a 63×1,32 NA oil objective.
Abbreviations
- AIF:
-
apoptosis inducing factor
- ANT:
-
adenine nucleotide translocator
- DDP:
-
X-linked deafness dystonia protein
- MS:
-
mass spectrometry
- PTPC:
-
permeability transition pore complex
- SIMPs:
-
soluble intermembrane space proteins
- VDAC:
-
voltage dependent anion channel
References
Kroemer G . (1997) Mitochondrial implication in apoptosis. Towards an endosymbiotic hypothesis of apoptosis evolution. Cell Death Differ. 4: 443–456
Kroemer G, Dallaporta B and Resche-Rigon M . (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60: 619–642
Susin SA, Zamzami N, Castedo M, Daugas E, Wang H-G, Geley S, Fassy F, Reed J and Kroemer G . (1997) The central executioner of apoptosis. Multiple links between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186: 25–37
sSteemans M, Goossens V, Van de Craen M, Van Herreweghe F, Vancompernolle K, De Vos K, Vandenabeele P and Grooten J . (1998) A caspase-activated factor (CAF) induces mitochondrial membrane depolarization and cytochrome c release by a non-proteolytic mechanism. J. Exp. Med. 188: 2193–2198
Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D and Reed JC . (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. U.S.A. 95: 4997–5002
Marzo I, Brenner C, Zamzami N, Jürgensmeier J, Susin SA, Vieira HLA, Prévost M-C, Xie Z, Mutsiyama S, Reed JC and Kroemer G . (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281: 2027–2031
Li H, Zhu H, Xu C and Yuan J . (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 4: 491–501
Scorrano L, Petronilli V, Di Lisa F and Bernardi P . (1999) Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J. Biol. Chem. 274: 22581–22585
Zamzami N, Susin SA, Marchetti P, Hirsch T, Gómez-Monterrey I, Castedo M and Kroemer G . (1996) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183: 1533–1544
Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M and Kroemer G . (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184: 1331–1342
Zamzami N, Marzo I, Susin SA, Brenner C, Larochette N, Marchetti P, Reed J, Kofler R and Kroemer G . (1998) The thiol-crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene 16: 1055–1063
Shimizu S, Narita M and Tsujimoto Y . (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483–487
Brenner C, Cardiou H, Vieira HLA, Zamzami N, Marzo I, Xie Z, Leber B, Andrews D, Duclohier H, Reed JC and Kroemer G . (1999) Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene. In press.
vander Heiden MG, Chandal NS, Williamson EK, Schumacker PT and Thompson CB . (1997) Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627–637
Liu XS, Kim CN, Yang J, Jemmerson R and Wang X . (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 86: 147–157
Single B, Leist M and Nicotera P . (1998) Simultaneous release of adenylate kinase and cytochrome c in cell death. Cell Death Differ. 5: 1001–1003
Kohler C, Gahm A, Noma T, Nahazawa A, Orrenius S and Zhivotovsky B . (1999) Release of adenylate kinase 2 from the mitochondrial intermembrane space during apoptosis. FEBS Lett. 447: 10–12
Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M and Kroemer G . (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184: 1331–1342
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM and Kroemer G . (1999) Molecular characterization of mitochondrial apoptosis-inducing factor (AIF). Nature 397: 441–446
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Larochette N, Alzari PM and Kroemer G . (1999) Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189: 381–394
Krajewski S, Krajewska M, Ellerby LM, Welsh K, Xie ZH, Deveraux QL, Salvesen GS, Bredesen DE, Rosenthal RE, Fiskum G and Reed JC . (1999) Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 96: 5752–5757
Samali A, Cai J, Zhivotovsky B, Jones DP and Orrenius S . (1999) Presence of a pre-apoptotic complex of procaspase-3, hsp60, and hsp10 in the mitochondrial fraction of Jurkat cells. EMBO J. 18: 2040–2048
Lorenzo HK, Susin SA, Penninger J and Kroemer G . (1999) Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 6: 516–524
Mintz PS, Patterson SD, Neuwald AF, Spahr CS and Spector DL . (1999) Purification and biochemical characterisation of interchromatin granule clusters. EMBO J. 18: 4308–4320
Link AS, Eng J, Schielzts DM, Carack E, Mize GJ, Morris DR, Garvik BM and Yates III JR . (1999) Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17: 676–682
Patterson SD . Using MS fragment-ion data to identify proteins from large sequence databases. In:Proteomics, Integrating Protein-based tools and application for drug discovery. L.M. Savage (ed.). International Business Communications, Inc.: Southborough pp. 127–135 1998
Vancompernolle K, Van Herrewghe F, Pynaert G, Van de Craen M, De Vos K, Totty N, Sterling A, Fiers W, Vandenabeele P and Grooten J . (1998) Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 6: 150–158
Voilley N, Roduit R, Vicaretti R, Bonny C, Waeber G, Dyck JRB, Lopaschuk GD and Prentki M . (1999) Cloning and expression of rat pancreatic beta-cell malonyl CoA decarboxylase. Biochem. J. 340: 213–217
Ashmarina LI, Psheshetsky AV, Branda SS, Isaya G and Mitchell GA . (1999) 3-hydroxy-3-methylglutaryl coenzyme A lysase: targeting and processing in peroxisomes and mitochondria. J. Lipid. Res. 40: 70–75
Danpure CJ . (1997) Variable peroxisomal and mitochondrial targeting of alanine glyoxylate aminotransferase in mammalian evolution and disease. Bioessays 19: 317–326
Xanthoudakis S, Roy S, Rasper D, Hennessey T, Aubin Y, Cassady R, Tawa P, Ruel R, Rosen A and Nicholson DW . (1999) Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J. 18: 2049–2056
Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H and Tsujimoto Y . (1998) Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. U.S.A. 95: 14681–14686
Marchetti P, Hirsch T, Zamzami N, Castedo M, Decaudin D, Susin SA, Masse B and Kroemer G . (1996) Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol. 157: 4830–4836
Hirsch T, Decaudin D, Susin SA, Marchetti P, Larochette N, Resche-Rigon M and Kroemer G . (1998) PK11195, a ligand of the mitochondrial benzodiazepin receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell. Res. 241: 426–434
Miccoli L, Poirson-Bichat F, Sureau F, Gonçalves RB, Bourgeois Y, Dutrillaux B, Poupon M-F and Oudard S . (1998) Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment. J. Natl. Cancer Inst. 90: 1400–1406
Carthy CM, Granville DJ, Jiang HJ, Levy JG, Rudin CM, Thompson CB, McManus BM and Hunt DWC . (1999) Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-XL overexpression do not prevent early mitochondrial events but still depress caspase activity. Lab. Invest. 79: 953–965
Koehler CM, Leuenberger D, Merchant S, Renold A, Junne T and Schatz G . (1999) Human deafness dystonia syndrome is a mitochondrial disease. Proc. Natl. Acad. Sci. U.S.A. 96: 2141–2146
Merrick BA, He CV, Witcher LL, Patterson RM, Reid JAJ, Pence Pawlowski PM and Selkirk JK . (1996) HSP binding and mitochondrial localization of p53 protein in human HT1080 and mouse C3H10T1/2 cell lines. Biochim. Biophys. Acta 1297: 57–68
Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and Kroemer G . (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182: 367–377
Susin SA, Larochette N, Geuskens M and Kroemer G . (1999) Purification of mitochondria for apoptosis assays. Methods Enzymol. in press
Pedersen PL, Grennawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW and Bustamente E . (1978) Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Meth. Cell Biol. 20: 411–481
Courchesne PL, Jones MD, Robinson JH, Spahr CS, McCracken S, Bentley DL, Luethy R and Patterson SD . (1998) Optimization of capillary chromatography ion trap mass spectrometry for identification of gel-separated proteins. Electrophoresis 19: 956–967
Courchesne PL, Luethy R and Patterson SD . (1997) Comparison of in-gel and on-membrane digestion methods at low to sub-pmol level for subsequent peptide and fragmentation mass analysis uding matrix-assisted laser-desorption ionization mass spectrometry. Electrophoresis 18: 369–381
Acknowledgements
This work has been supported by a special grant from the Ligue Nationale contre le Cancer as well as grants from ANRS and FRM (to G Kroemer), Assistance Publique-Hôpitaux de Paris and CANAM (contract 98006 to E Daugas).
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by R Knight
Rights and permissions
About this article
Cite this article
Patterson, S., Spahr, C., Daugas, E. et al. Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ 7, 137–144 (2000). https://doi.org/10.1038/sj.cdd.4400640
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400640
Keywords
This article is cited by
-
MTCH2 is differentially expressed in rat testis and mainly related to apoptosis of spermatocytes
Cell and Tissue Research (2015)
-
Endonuclease G interacts with histone H2B and DNA topoisomerase II alpha during apoptosis
Molecular and Cellular Biochemistry (2012)
-
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
Oncogene (2011)
-
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
Cell Death & Differentiation (2009)